| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Levofloxacin]] 500 mg po q24h for 14 days '''''<BR> OR <BR> ▸'''''[[Moxifloxacin]] 400 mg po q24h for 14 days'''''
|-
|}
|}
{| class="mw-collapsible mw-collapsed" id="mw-customcollapsible-table2" style="background: #FFFFFF;"
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Azithromycin]] 500 mg day 1, then 250 mg days 2-5 '''''<BR> OR <BR> ▸'''''[[Erythromycin]] 500 mg 4 times daily x 14 days '''''
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |'''''Infant 1-5 mo of age'''''
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Clarithromycin]] 15 mg/kg/d in two divided doses x 7 days '''''<BR> OR <BR> ▸'''''[[TMP-SMX]] CONTRAINDICATED for age < 2 months''''' <br> '''''(8/40 mg/kg/day) in two divided doses x 14 days '''''
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Clarithromycin]] 15 mg/kg/d in two divided doses (max dose 1 gm/day) x 7 days '''''<BR> OR <BR> ▸'''''[[TMP-SMX]] 8/40 mg/kg/day in two divided doses x 14 days)'''''
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Clarithromycin]] 500 mg 2 x/day x 7 days '''''<BR> OR <BR> ▸'''''[[TMP-SMX]] 320/1600 mg/day in two divided doses x 14 days '''''
|-
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left |'''''<sup>†</sup> = Recommended agent ; Clarithromycin and TMP-SMX are contraindicated in children below 6 mths and 2 mths respectively'''''
Bronchitis is usually caused by a viral agent. The treatment of bronchitis is usually symptomatic with analgesics, decongestants, cough suppressant (codeine or hydrocodone-containing preparations or inhaled corticosteroids). Use of antibiotics should be limited to conditions when a diagnosis with a definitive pathogen is there. Oseltamivir for influenza (during influenza epidemics), and azithromycin for atypical bacterias like mycoplasma, chlamydiae has been shown useful in clinical trials.
Medical Therapy
Acute Bronchitis
Symptomatic
Treatment for acute bronchitis is primarily symptomatic.
Decongestants can be useful in patients with nasal congestion, and
Expectorants may be used to loosen mucus and increase expulsion of sputum.
Cough suppressants may be used if the cough interferes with sleep or is bothersome, although coughing may be useful in expelling sputum from the airways. Even with no treatment, most cases of acute bronchitis resolve quickly.
Antimicrobial Agent
Only about 5–10% of bronchitis cases are caused by a bacterial infection. Most cases of bronchitis are caused by a viral infection and are "self-limiting" and resolve themselves in a few weeks.[1]
Antimicrobial agents are not recommended in most cases of acute bronchitis. Various randomized controlled trials and systematic reviews have shown a decrease in symptoms by just a fraction of day with use of antibiotics when compared with placebo. These results though statistically significant are not clinically significant (as improvement by only a fraction of day). Antibiotic therapy did not help in a trial of patients who mainly had bronchitis.[2] About 15% had chronic obstructive lung disease and their results were not reported separately.[2]
However, treatment with antibiotics can be administered in cases with a definitive treatable pathogen is there. For e.g. treatment of influenza virus with oseltamivir decrease the duration of symptoms by approximately 1 day and result in an earlier return to normal activity Similarly, treatment of patients with pertussis is indicated to limit transmission when the therapy is initiated during the first week of symptoms. However, the symptoms are not less severe even with administration of these antibiotics.
Thus, in case of definitive diagnosis antibiotics can be used for:
Azithromycin (Zithromax) 500mg on day 1 followed by 250mg from day 2-5.
Other Therapy
Various other treatments like beta 2 agonist, mucolytic agents, anti-tussive agent and corticosteroids have been used in different settings but no proven benefits have been shown in any of the clinical trials.
Chronic Bronchitis Treatment
Chronic bronchitis is treated symptomatically. Inflammation and edema of the respiratory epithelium may be reduced with inhaled corticosteroids. Wheezing and shortness of breath can be treated by reducing bronchospasm (reversible narrowing of smaller bronchi due to constriction of the smooth muscle) with bronchodilators such as inhaled β-Adrenergic agonists (e.g., salbutamol) and inhaled anticholinergics (e.g., ipratropium bromide). Hypoxemia, too little oxygen in the blood, can be treated with supplemental oxygen. However, oxygen supplementation can result in decreased respiratory drive, leading to increased blood levels of carbon dioxide and subsequent respiratory acidosis.
The most effective method of preventing chronic bronchitis and other forms of COPD is to avoid smoking cigarettes and other forms of tobacco.
On pulmonary tests, a bronchitic (bronchitis) may present a decreased FEV1 and FEV1/FVC. However, unlike the other common obstructive disorders, asthma and emphysema, bronchitis rarely causes a high residual volume. This is because the air flow obstruction found in bronchitis is due to increased resistance, which, in general, does not cause the airways to collapse prematurely and trap air in the lungs.[citation needed]
Antibiotics
In most cases, acute bronchitis is caused by viruses, not bacteria and it will go away on its own without antibiotics. To treat acute bronchitis that appears to be caused by a bacterial infection, or as a precaution, antibiotics may be given.[3]
If antibiotics are used, a meta-analysis found that "amoxicillin/clavulanic acid, macrolides, second-generation or third-generation cephalosporins, and quinolones" may be more effective.[4]
Bronchitis, Infants/Children (Age < 5 years)
Antibiotics are not indicated usually except for a few conditions like:
↑Dimopoulos G, Siempos II, Korbila IP, Manta KG, Falagas ME (2007). "Comparison of first-line with second-line antibiotics for acute exacerbations of chronic bronchitis: a metaanalysis of randomized controlled trials to Joe Fo Sho". Chest. 132 (2): 447–55. doi:10.1378/chest.07-0149. PMID17573508.CS1 maint: Multiple names: authors list (link)